基因疗法在免疫调节和β细胞保存中的新兴作用在1型糖尿病中
Rahul Mittal1,2, Vedaant Mutha1,3, Eavin A Valerio1,3
1Diabetes Research Institute, University of Miami Miller School of Medicine, Miami, FL, USA.
Journal of drug targeting
|June 20, 2025
概括
基因疗法通过向β细胞破坏和免疫问题,为1型糖尿病 (T1D) 提供了一种有前途的方法. 本综述检查了当前的基因疗法策略和T1D治疗的挑战.
科学领域:
- 免疫学 免疫学 免疫学
- 内分泌学 在内分泌学.
- 遗传学 是一个遗传学.
背景情况:
- 1型糖尿病 (T1D) 涉及胰岛素生成β细胞的自身免疫破坏,导致高血糖和胰岛素依赖.
- 目前的糖尿病管理面临着实现最佳血糖控制和预防长期并发症的挑战.
研究的目的:
- 系统地审查T1D的基因疗法的当前状态.
- 评估对T1D基因治疗方法的临床前和临床发现.
- 确定T1D治疗中基因疗法的挑战和未来方向.
主要方法:
- 对T1D基因治疗的临床前研究和临床试验的系统审查.
- 对基因疗法策略的分析,包括病毒载体 (AAV,晶体病毒),CRISPR/Cas9和非病毒系统.
- 对β细胞再生,免疫耐受性诱导和代谢调节的方法的评估.
主要成果:
- 基因疗法显示使用病毒载体来保护胰腺功能和免疫平衡的可行性.
- 像CRISPR/Cas9和非病毒传递这样的创新策略解决了安全性和有效性的问题.
- 关键的方法侧重于β细胞再生,免疫耐受性和代谢调节.
结论:
- 基因疗法是T1D的转变性方法,针对其根本原因.
- 需要克服交付效率,长期影响和可扩展性方面的挑战.
- 进一步的研究和临床转化对于开发基因疗法作为可行的T1D治疗至关重要.
相关概念视频
Gene Therapy
25.9K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.9K
Diabetes Mellitus: Overview and Type I Subtype
3.3K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
3.3K
Microorganisms in Medicine and Therapeutics
375
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
375
Diabetes Mellitus: Type 2 and Gestational
3.0K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.0K
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
1.4K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
1.4K
Pathophysiology of Diabetes
1.2K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.2K


